Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Urethritis Treatment Guidelines

Primary Causative Organisms and Treatment Implications

  • The Centers for Disease Control and Prevention recommends that doxycycline or azithromycin be selected based on local resistance patterns and patient-specific factors for non-gonococcal urethritis 1
  • For gonococcal urethritis, the Centers for Disease Control and Prevention recommends ceftriaxone as the current standard of care, with fluoroquinolones considered if susceptibility is confirmed and local resistance rates are acceptable 1
  • The Centers for Disease Control and Prevention suggests differentiating between gonococcal and non-gonococcal urethritis to determine appropriate antimicrobial selection, and considering that persistent urethritis after treatment may be caused by C. trachomatis or other organisms 1

Clinical Approach to Urethritis

  • Local resistance rates to TMP-SMX should be documented to be <20% for consideration of use, according to Clinical Microbiology and Infection 3

Important Caveats

  • Antimicrobial selection should prioritize agents with known local susceptibility patterns, as reported by The Journal of Urology, European Urology, and other sources 4, 5, 6
  • Clinical efficacy of TMP-SMX drops dramatically with resistant organisms, with an 84% cure rate with susceptible organisms versus only 41% with resistant organisms, as noted by Praxis Medical Insights 2